Disease Target Structure Research Center, Division of Biomedical Research, KRIBB, 34141, Daejeon, Republic of Korea.
Critical Diseases Diagnostics Convergence Research Center, KRIBB, 34141, Daejeon, Republic of Korea.
Chem Asian J. 2022 Oct 4;17(19):e202200679. doi: 10.1002/asia.202200679. Epub 2022 Aug 18.
Biomolecular interactions, such as protein-protein, protein-nucleic acid, and protein/nucleic acid-ligand interactions, play crucial roles in various cellular signaling and biological processes, and offer attractive therapeutic targets in numerous human diseases. Currently, drug discovery is limited by the low efficiency and high cost of conventional ensemble-averaging-based techniques for biomolecular interaction analysis and high-throughput drug screening. Nanopores are an emerging technology for single-molecule sensing of biomolecules. Owing to the notable merits of single-molecule sensing, nanopore sensors have contributed tremendously to nucleic acid sequencing and disease diagnostics. In this minireview, we summarize the recent developments and outlooks in single-molecule sensing of various biomolecular interactions for drug discovery applications using biological and solid-state nanopore sensors.
生物分子相互作用,如蛋白质-蛋白质、蛋白质-核酸和蛋白质/核酸-配体相互作用,在各种细胞信号转导和生物过程中发挥着关键作用,并为许多人类疾病提供了有吸引力的治疗靶点。目前,药物发现受到传统基于集合平均的生物分子相互作用分析和高通量药物筛选技术效率低和成本高的限制。纳米孔是用于生物分子单分子传感的新兴技术。由于单分子传感的显著优点,纳米孔传感器在核酸测序和疾病诊断方面做出了巨大贡献。在这篇综述中,我们总结了使用生物和固态纳米孔传感器在药物发现应用中对各种生物分子相互作用进行单分子传感的最新进展和展望。